Ligand Pharmaceuticals | LGND - Stock


Ligand Pharmaceuticals reported $13.27M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Amgen USD 6.19B 39M Mar/2026
Anika Therapeutics USD 22.84M 4.05M Mar/2026
Arrowhead Research USD -173.08M 173.08M Dec/2024
Baxter International USD 2.32B 84M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Eli Lilly USD 14.53B 785M Mar/2026
Enviri Corporation USD 173.28M 7.27M Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Glaxosmithkline GBP 6.12B 46M Sep/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 132.91M 841K Mar/2026
Intrexon USD 287K 68K Dec/2022
Ionis Pharmaceuticals USD 5.56M 4.49M Mar/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
Ligand Pharmaceuticals USD 13.27M 4.14M Mar/2026
MacroGenics USD 9.5M 1.59M Mar/2026
Merck USD 6.48B 179M Mar/2026
Pacira USD 150.37M 2.49M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Veracyte USD 21.42M 870K Mar/2026